Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Auris Medical (EARS)

0.9352   -0.02 (-2.05%) 06-04 15:59
Open: 0.98 Pre. Close: 0.9548
High: 0.98 Low: 0.9302
Volume: 102,539 Market Cap: 4M
Auris Medical Holding AG is a clinical-stage biopharmaceutical company. It is engaged in the development of novel products for the treatment of inner ear disorders. Its product candidate is AM-101.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.982 - 0.987 0.987 - 0.994
Low: 0.915 - 0.921 0.921 - 0.927
Close: 0.929 - 0.939 0.939 - 0.95

Technical analysis

as of: 2020-06-04 4:30:37 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.35     One year: 1.61
Support: Support1: 0.80    Support2: 0.67
Resistance: Resistance1: 1.16    Resistance2: 1.38
Pivot: 1.03
Moving Average: MA(5): 0.97     MA(20): 1.02
MA(100): 1.08     MA(250): 1.78
MACD: MACD(12,26): 0.01     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 24.50     %D(3): 28.43
RSI: RSI(14): 43.44
52-week: High: 3.20  Low: 0.65  Change(%): -68.3
Average Vol(K): 3-Month: 21449  10-Days: 35309

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
EARS has closed above bottom band by 15.5%. Bollinger Bands are 18.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 10 May 2020
Here's Why We Worry About Auris Medical Holding's (NASDAQ:EARS) Cash Burn Situation - Yahoo Finance

Tue, 26 May 2020
Auris Medical Announces Positive Top-Line Data from AM-201 Phase 1b Study in Antipsychotic-Induced Weight Gain and Provides Update on TRAVERS Phase 2 Study - GlobeNewswire

Fri, 22 May 2020
Who Has Been Buying Auris Medical Holding Ltd. (NASDAQ:EARS) Shares? - Simply Wall St

Fri, 15 May 2020
Auris Medical Holding Ltd. (NASDAQ:EARS) Stock: Worth Taking a Bite? - State Reviewer

Tue, 26 May 2020
Is Auris Medical Holding Ltd (EARS) Stock a Smart Investment? - InvestorsObserver

Wed, 06 May 2020
Analysts Have Mixed Ratings On Auris Medical Holding Ltd. (NASDAQ:EARS), Liberty TripAdvisor Holdings Inc. (NASDAQ:LTRPA) - State Reviewer

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 5
Shares Float (M) 4
% Held by Insiders 8.70
% Held by Institutions 6.63
Shares Short (K) 12
Shares Short P. Month (K) 7

Stock Financials

EPS -1.327
EPS Est This Year -0.630
EPS Est Next Year -0.440
Book Value (p.s.) -0.030
Profit Margin
Operating Margin
Return on Assets (ttm) -47.5
Return on Equity (ttm) -136.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -0.70
PEG Ratio
Price to Book value -31.17
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.